Trial Profile
Study of Apatinib in Metastatic Esophageal Cancer A Open Label, Randomized Clinical Trial
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 05 Feb 2018
Price :
$35
*
At a glance
- Drugs Rivoceranib (Primary)
- Indications Oesophageal cancer
- Focus Therapeutic Use
- 23 Feb 2016 New trial record